Found 0 matching trials
Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer
PHASE2This is a randomized, double blind, multi-institutional phase II therapeuti...
Location
University of Illinois Medical Center
Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer
PHASE2This randomized phase II trial studies how well giving sipuleucel-T with or...
Location
City of Hope Medical Center
Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancer
PHASE2This randomized pilot clinical trial studies sipuleucel-T with or without d...
Location
University of Wisconsin Carbone Cancer Center
Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
PHASE2This randomized phase II trial studies how well sipuleucel-T with or withou...
Location
Roswell Park Cancer Institute
Blood for Immune Response to Provenge® in HRPC
N/AThis study is being conducted to assess and monitor immune response in pati...
Location
Multiple Locations
Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer
PHASE1Proposed immunotherapy with an extended course of Sipuleucel-T treatment ma...
Status
Active Not Recruiting
Location
University of Oklahoma Health Sciences Center, Stephenson Cancer Center
Sipuleucel-T as Neoadjuvant Treatment in Prostate Cancer
PHASE2This is an open label, Phase 2 trial of immunotherapy with sipuleucel-T as ...
Location
USC / Norris Comprehensive Cancer Center
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen
PHASE2This is a randomized, multicenter, single blind, Phase 2 trial of immunothe...
Location
UCSD Moores Cancer Center
Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Resistant (mAPMR) Prostate Cancer
PHASE1This phase Ib single-center open-label de-escalation study uses a modified ...
Location
Washington University School of Medicine
Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer
PHASE2This study is designed to test the hypothesis that using Sipuleucel-T (Prov...
Status
Active Not Recruiting
Location
Moffitt Cancer Center